ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Eugene K. W. Sim
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haider, H. Kh.
Right arrow Articles by Sim, E. K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haider, H. Kh.
Right arrow Articles by Sim, E. K. W.
Related Collections
Right arrow Molecular biology

Ann Thorac Surg 2004;77:1133
© 2004 The Society of Thoracic Surgeons

Correspondence

Immunosuppression and xenotransplantation of cells for cardiac repair

Husnain Kh. Haider, MPharm, PhD

Department of Cardiothoracic and Vascular Surgery, National University of Singapore, Singapore 117597, Singapore

Lei Ye, MD, Shujia Jiang, MD

10 Medical Dr, National University of Singapore, Singapore 117597, Singapore

Peter K. Law, PhD

Cell Therapy, Inc, 1770 Moriah Woods Blvd, Suite 18, Memphis, TN 38117, USA

Eugene K. W. Sim, FRCS

Department of Cardiac, Thoracic and Vascular Surgery, National University Hospital, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore

e-mail: khhaider@hotmail.com
e-mail: sursimkw@nus.edu.sg

The first 20% of the full text of this article appears below.

To the Editor:

We read with interest the article by Min and colleagues [1]. The authors successfully performed cotransplantation of human fetal cardiomyocytes and human mesenchymal stem cells in a model of myocardial infarction. A more intriguing and interesting aspect of the study was the survival of the human cell xenograft for up to 6 weeks in a porcine host. Donor-specific tolerance was achieved by immunosuppression using 15 . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.